Start of Health Insurance Coverage for Infertility Treatment Drugs
First written in FY2022-Q2. 5 of 6 entries say "Restated". Latest entry: FY2023-Q3.
No other company in this theme has enough history to compare yet.
- FY2023-Q3RestatedAnnual report
「Utrogestan Vaginal Capsules 200 mg, a natural progesterone formulation indicated for “luteal support in assisted reproductive medicine,” which was listed in the National Health Insurance Drug Price List in April 2022 as a drug used in infertility treatment」
The company continues to disclose the fact that Utrogestan Vaginal Capsules 200 mg was listed in the National Health Insurance Drug Price List as a drug for infertility treatment in April 2022. - FY2023-Q2RestatedAnnual report
「Utrogestan Vaginal Capsules 200 mg, a natural progesterone formulation indicated for “luteal support in assisted reproductive medicine,” which was listed in the National Health Insurance Drug Price List in April 2022 as a drug used in infertility treatment」
The company continues to disclose the fact that Utrogestan Vaginal Capsules 200 mg was listed in the National Health Insurance Drug Price List as a drug for infertility treatment in April 2022. - FY2023-Q1RestatedAnnual report
「Utrogestan Vaginal Capsules 200 mg, a natural progesterone formulation indicated for “luteal support in assisted reproductive medicine,” which was listed in the National Health Insurance Drug Price List in April 2022 as a drug used in infertility treatment」
The company continues to disclose the fact that Utrogestan Vaginal Capsules 200 mg was listed in the National Health Insurance Drug Price List as a drug for infertility treatment from April 2022. - FY2022RestatedAnnual report
「As a result, several of our products, including Utrogestan Vaginal Capsules 200 mg, became newly covered by health insurance as drugs used in infertility treatment from April 2022.」
The company continues to disclose the fact that several products, including Utrogestan Vaginal Capsules 200 mg, became covered by health insurance as drugs for infertility treatment from April 2022. - FY2022-Q3RestatedAnnual report
「As a result, several of our products, including Utrogestan Vaginal Capsules 200 mg, became newly covered by health insurance as drugs used in infertility treatment from April 2022.」
The company continues to disclose the fact that several products, including Utrogestan Vaginal Capsules 200 mg, became covered by health insurance as drugs for infertility treatment from April 2022. - FY2022-Q2First statedAnnual report
「As the declining birthrate became an urgent social issue, the government policy set out in the Basic Plan for Measures to Address the Declining Birthrate, approved by the Cabinet on 29 May 2020, called for consideration of broad health insurance coverage for treatments with clearly established indications and efficacy, in order to reduce the financial burden of infertility treatment. At the 138th Medical Insurance Subcommittee of the Social Security Council on 23 December of the same year, it was concluded that health insurance coverage for drugs used in infertility treatment would begin in April 2022. As a result, several of our products, including Utrogestan Vaginal Capsules 200 mg, became newly covered by health insurance as drugs used in infertility treatment from April 2022.」
Against the backdrop of the government policy and the conclusion of the Social Security Council, the company states as a new business and institutional development that several products, including Utrogestan Vaginal Capsules 200 mg, became covered by health insurance as drugs for infertility treatment from April 2022.